These trials completed more than 12 months ago and should have reported results. Some have, some have not.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
|Status||Trial ID||Title||Completion date||Category|
|Listed as ongoing, but also has a completion date||2006-001782-42||Efficacy and tolerability of a new oral extended-release formulation containing Low Molecular Weight Heparin (CB-01-05-MMX), administered as add-on therapy to oral mesalazine or other 5-ASA derivative...||2007-12-19||bad-data|
|Listed as ongoing, but also has a completion date||2006-004776-12||Efficacy and safety of oral budesonide-MMX™ (CB-01-02) 6 mg and 9 mg extended release tablets in patients with mild or moderate active ulcerative colitis. A multicentre, randomised, double-blind, dou...||2010-12-13||bad-data|
|Completed, but no date||2007-007702-30||Feasibility and safety of Infliximab enema treatment in patients with active left-sided ulcerative colitis. An open-label, non comparative, pilot study.||bad-data|
|Not reported||2008-003913-28||Randomised, double-blind,multicentre,12 months extension study to evaluate the safety and the efficacy of daily Budesonide MMX 6mg vs placebo in the maintenance of remission in subjects with ulcerativ...||2011-05-16||due-trials|
|Not reported||2011-001173-24||Colon staining efficacy of single oral doses of methylene blue MMX modified release tablets administered to patients undergoing colonoscopy||2012-01-16||due-trials|
|Not reported||2011-005693-36||Intraepithelial neoplasia detection rate after single oral dose of methylene blue MMX modified release tablets administered to patients with long standing ulcerative colitis undergoing colonoscopy||2012-07-04||due-trials|
|Completed, but no date||2011-005694-23||Polyp detection rate after single oral dose of methylene blue MMX(R) modified release tablets administered to subjects undergoing outpatients colonoscopy||bad-data|
|Listed as ongoing, but also has a completion date||2012-003983-32||The safety and efficacy of Methylene Blue MMX® modified release tablets administered to subjects undergoing screening or surveillance colonoscopy.||2016-10-27||bad-data|
|Completed, but no date||2013-000452-18||Staining efficacy and safety of Methylene Blue enemas in patients undergoing flexible rectosigmoidoscopy||bad-data|
|Completed, but no date||2013-000634-35||Effect of oral administration of Methylene Blue MMX® tablets on double-stranded DNA damage assessed by γH2AX analysis of colon biopsy samples||bad-data|
|Other||2016-004977-42||A Phase II, multicentre, randomised, double-blind, placebo controlled, proof of concept study of efficacy and safety of Rifamycin SV-MMX® 600 mg tablets administered three or two times daily to patien...||not-yet-due|